Inventor · disambiguated record
Manoj Sharma
Also filed as: SHARMA MANOJ · SHARMA MANOJ K
10 granted patents·7 pending applications·79 citations·filing 2012–2025
85Inventor score
Files withSIEMENS HEALTHCARE DIAGNOSTICS INC10MERCK SHARP & DOHME LLC4DYNAMIC BIOLOGICS INC1MERCK SHARP & DOHME1SHARMA MANOJ K1
Top patents by PatentIndex Score
17 records- 0193US11377483B2Sandwich assay design for small moleculesSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2020·Granted Jul 5, 2022·2 cites·13 claims
- 0288US11633476B2Stable formulations of programmed death receptor 1 (PD-1) antibodies and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2018·Granted Apr 25, 2023·6 cites·21 claims
- 0386US9220776B2Stable formulations of antibodies to human programmed death receptor PD-1 and related treatmentsSHARMA MANOJ K·Filed 2012·Granted Dec 29, 2015·67 cites·13 claims
- 0481US9804176B2Assays for vitamin D epimersSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2015·Granted Oct 31, 2017·2 cites·12 claims
- 0579US2023263887A1Stable formulations of programmed death receptor 1 (pd-1) antibodies and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 0679US2023321234A1Stable formulations of programmed death receptor 1 (pd-1) antibodies and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 0770US9746484B2Binding partners specific for vitamin D epimers in vitamin D assaysSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2015·Granted Aug 29, 2017·1 cites·12 claims
- 0870US2025074985A1Stable formulations of anti-ctla4 antibodies alone and in combination with programmed death receptor 1 (pd-1) antibodies and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2024·Application pending·0 cites
- 0965US9815907B2Binding partners specific for vitamin D epimersSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2015·Granted Nov 14, 2017·1 cites·6 claims
- 1061US12509506B2Anti-Hog TCN1 monoclonal antibodies and methods of production and use thereofSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2020·Granted Dec 30, 2025·0 cites·26 claims
- 1159US2025304722A1Anti-naloxone and anti-naltrexone monoclonal antibodies and methods of production and use thereofSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2025·Application pending·0 cites
- 1255US2017362305A1Sandwich assay design for small moleculesSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2015·Application pending·0 cites
- 1352US10399938B2Compositions relating to vitamin DSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2018·Granted Sep 3, 2019·0 cites·7 claims
- 1452US2020262922A1Stable formulations of anti-ctla4 antibodies alone and in combination with programmed death receptor 1 (pd-1) antibodies and methods of use thereofMERCK SHARP & DOHME·Filed 2018·Application pending·0 cites
- 1549US12404346B2Anti-naloxone and anti-naltrexone monoclonal antibodies and methods of production and use thereofSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2020·Granted Sep 2, 2025·0 cites·18 claims
- 1646US10106498B2Compositions relating to vitamin DSIEMENS HEALTHCARE DIAGNOSTICS INC·Filed 2015·Granted Oct 23, 2018·0 cites·12 claims
- 1742US2022251295A1Levodopa polymeric conjugates, formulations thereof, and their uses for the treatment of parkinson's diseaseDYNAMIC BIOLOGICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Manoj Sharma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →